Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
18 hedge funds and large institutions have $3.42M invested in Vaxart in 2018 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 18 closing their positions.
7.5% more ownership
Funds ownership: 1.58% → 9.08% (+7.5%)
10% less capital invested
Capital invested by funds: $3.81M → $3.42M (-$393K)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
47% less funds holding
Funds holding: 34 → 18 (-16)
89% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$258K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$169K |
| 3 |
CCM
Carlson Capital Management
Northfield,
Minnesota
|
+$91.9K |
| 4 |
Goldman Sachs
New York
|
+$67.2K |
| 5 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
+$64.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WT
Wellcome Trust
London,
United Kingdom
|
-$72K |
| 2 |
California Public Employees Retirement System
Sacramento,
California
|
-$56K |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
-$36K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$36K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$30K |
VXRT Hedge Fund Activity: Q1 2018 in Review
18 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q1 2018, worth a combined $3.42M — down 10% from $3.81M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of VXRT and 2 opened new positions — a net loss of 16 holders — while 9 trimmed existing stakes and 6 added.
The largest buyer was Renaissance Technologies, adding an estimated $258K. The largest seller was Wellcome Trust, exiting entirely with an estimated $72K sold.
- 18 institutional investors held Vaxart (VXRT) as of Q1 2018, down from 34 in Q4 2017.
- Funds reported $3.42M of Vaxart stock for Q1 2018, down 10% quarter-over-quarter.
- 2 funds opened new Vaxart positions in Q1 2018 and 18 closed out, a net change of -16 holders.
- The largest Vaxart buyer in Q1 2018 was Renaissance Technologies, an estimated $258K added.
- The largest Vaxart seller in Q1 2018 was Wellcome Trust, an estimated $72K sold.
Based on aggregated 13F filings for Q1 2018.